Genetic blood testing for transplant patients (allomap and allosure)

Active Awarded Last action

Contract number
36C24926N0622
Awardee
Awarding agency
Obligated
$1,049,561

Award facts

Contract value 100% obligated
$1,049,560.80 Current and potential, with all options
Completion date 10% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Murfreesboro, TN 37129, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $557,818
Original award $491,742

About this award

Veterans Integrated Service Network 9 issued a $1,049,560.80 delivery order to CareDx, Inc. on September 23, 2026, for genetic blood testing for transplant patients using AlloMap and AlloSure diagnostic tests, with performance through September 22, 2027.

Place of performance is Murfreesboro, Tennessee. The order is priced on a firm fixed price basis with no set-aside. CareDx operates as a prime contractor without subcontractors and provides proprietary genetic and molecular diagnostic testing services to assess organ rejection risk in transplant recipients across the VA's regional networks.

Quick answers

Who was awarded contract 36C24926N0622?

36C24926N0622 was awarded to Caredx, Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on September 23, 2026.

How much is contract 36C24926N0622 worth?

The government has obligated $1,049,561 on 36C24926N0622.

Is contract 36C24926N0622 an order under another contract?

Yes. 36C24926N0622 is a delivery order under 36C24922D0027, an indefinite delivery contract.

Was contract 36C24926N0622 competed?

The extent of competition for 36C24926N0622 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award